ライフサイエンスコーパス: murine monoclonal antibody

1 CML28 was used to generate a CML28-specific murine monoclonal antibody.

2 cytometry using FITC-conjugated anti-rat IgM murine monoclonal antibody.

3 ine pancreas was used to generate a panel of murine monoclonal antibodies.

4 y after single administration was lower than murine monoclonal antibodies.

5 es have been defined and characterized using murine monoclonal antibodies.

6 ified enzyme was used to generate a panel of murine monoclonal antibodies.

7 ously defined epitopes for broadly conserved murine monoclonal antibodies.

8 ked immunosorbent assay using group-specific murine monoclonal antibodies.

9 ) and light (L) chains were determined for a murine monoclonal antibody, 12/231/93, which is specific

10 Because murine monoclonal antibody 13-1 possesses target-specifi

11 A murine monoclonal antibody, 14B7, has been reported to i

12 in an orthotopic murine xenograft using the murine monoclonal antibody 17.1A conjugated to the photo

13 To target PS on tumor vasculature, the murine monoclonal antibody 3G4 was developed.

14 A murine monoclonal antibody, 4D5, to the extracellular do

15 c efficacy of astatine-211 ((211)At)-labeled murine monoclonal antibody 7G7/B6 alone and in combinati

16 that reduced binding and neutralization by a murine monoclonal antibody (A20) were localized, while m

17 the anti-vascular endothelial growth factor murine monoclonal antibody A4.6.1.

18 al growth factor receptor chimeric human and murine monoclonal antibody, administered with cisplatin

19 celiac-toxic epitopes was measured by using murine monoclonal antibodies against gliadin and high-mo

20 We have generated cross-reactive murine monoclonal antibodies against human and mouse C3d

21 Murine monoclonal antibodies against Netrin-1, Unc5b, or

22 ecular rationale for the inability to obtain murine monoclonal antibodies against the receptor bindin

23 chemotaxis of human VSMCs that is blocked by murine monoclonal antibody against CCR8 and by the G-pro

24 nal anti-CCR8 antibody and a newly developed murine monoclonal antibody against CCR8 inhibited this a

25 man macrophages using virions opsonized by a murine monoclonal antibody against the MV hemagglutinin

26 the immune response, which develops against murine monoclonal antibodies, allowing for multiple dose

27 Diverse epitopes recognized by three murine monoclonal antibodies and 24 individual human ser

28 Competition with well-characterized murine monoclonal antibodies and immunodetection of gD t

29 finity-purified immunoglobulin fractions and murine monoclonal antibodies and show that antibodies to

30 Previously, we described a murine monoclonal antibody, anti-CotH C2, which protecte

31 pitope recognized by a broadly neutralizing, murine monoclonal antibody, AP33.

32 Fv antibody fragments from the CD20-specific murine monoclonal antibody B9E9 were genetically enginee

33 We have developed a murine monoclonal antibody, BAH-1, raised against human

34 the present study we have identified a novel murine monoclonal antibody, BOB93, which bound to the su

35 (90)Y-ibritumomab tiuxetan consists of a murine monoclonal antibody covalently attached to a meta

36 A murine monoclonal antibody, CP.B8, specific for the extr

37 e further characterized the targeting of the murine monoclonal antibody DAB4 specifically to dead tum

38 Murine monoclonal antibodies directed against proteins o

39 A murine monoclonal antibody directed against Borrelia bur

40 As a model we used T101, a murine monoclonal antibody directed against CD5 antigen.

41 assigned to receive 2 doses of either E5, a murine monoclonal antibody directed against endotoxin (n

42 been most widely used clinically is OKT3, a murine monoclonal antibody directed against the CD3 rece

43 uzumab (HuM195) is an unconjugated humanized murine monoclonal antibody directed against the cell sur

44 A humanized murine monoclonal antibody directed to the Fc epsilonR1-

45 ignificant limitation to the repeated use of murine monoclonal antibodies for treatment of transplant

46 We identified vaccine-elicited murine monoclonal antibodies from distinct classes capab

47 All of the murine monoclonal antibodies generated to full-length Pv

48 Murine monoclonal antibody GNC92H2 was elicited by activ

49 e characterization of a broadly neutralizing murine monoclonal antibody, H5M9, to most H5N1 clades an

50 The binding of murine monoclonal antibody HyHEL-5 to lysozyme has been

51 Anti-LF murine monoclonal antibodies immobilized on magnetic pro

52 e number of isolates that did not react with murine monoclonal antibodies indicates that DNA sequence

53 neutralizing epitopes on gD2 are targeted by murine monoclonal antibodies, it is not known whether th

54 man platelet factor 4 (PF4)/heparin-specific murine monoclonal antibody (KKO) binds to peripheral blo

55 The murine monoclonal antibody LA-2 defines an important pro

56 A murine monoclonal antibody (MA-33B8), raised against the

57 ation of each of the 3 human FcgammaR, using murine monoclonal antibodies (mAb) to each receptor as a

58 Two murine monoclonal antibodies (MAb), 2C5-F10 and 8D1-H10,

59 rmined the affinities of two cocaine-binding murine monoclonal antibodies (mAb: clones 3P1A6 and MM02

60 We have characterized a murine monoclonal antibody (MAb 35), which was raised ag

61 The bispecific murine monoclonal antibody (MAb) 1A10 has specificity fo

62 The murine monoclonal antibody (MAb) 2D7, which recognizes a

63 (1), IgG(2a), and IgG(2b) switch variants of murine monoclonal antibody (mAb) 3E5 IgG(3) with identic

64 ducreyi 35000 defective in expression of the murine monoclonal antibody (MAb) 3F11 epitope on H. ducr

65 The murine monoclonal antibody (mAb) 62-71-3 was recently id

66 haracterization, and in vivo evaluation of a murine monoclonal antibody (MAb) against ClfA.

67 y, the use of a radiolabeled fibril-reactive murine monoclonal antibody (mAb) as an amyloid-specific

68 imicrotubule agent, covalently linked to the murine monoclonal antibody (mAb) B-B4 targeting syndecan

69 We investigated the functional activity of murine monoclonal antibody (MAb) B5 that recognizes a hi

70 igated the antigenic targets of a protective murine monoclonal antibody (MAb) prepared against a N-Pr

71 COL-1 is a high-affinity murine monoclonal antibody (MAb) specific for carcinoemb

72 III coat protein of fd phage using C355.1, a murine monoclonal antibody (mAb) that recognizes a confo

73 Moreover, AP33, a neutralizing murine monoclonal antibody (MAb) to a linear epitope in

74 To circumvent this problem, we developed a murine monoclonal antibody (mAb) to human (h) PF4/hepari

75 In this study, a murine monoclonal antibody (MAb) to PcrV was generated:

76 A murine monoclonal antibody (MAb) with human CD4 specific

77 study tested the hypothesis that a humanized murine monoclonal antibody (MAb) would protect against R

78 An immunoglobulin G3 murine monoclonal antibody (MAb), designated MAb B5, was

79 We have previously described a murine monoclonal antibody (mAb), F28C4, directed agains

80 A murine monoclonal antibody mAb735 has a unique preferenc

81 Here, we identify a panel of 18 neutralizing murine monoclonal antibodies (mAbs) against the EEEV E2

82 Some murine monoclonal antibodies (MAbs) against the glucuron

83 Murine monoclonal antibodies (MAbs) have been generated

84 d evaluated for the effects of GPVI-specific murine monoclonal antibodies (mAbs) on platelet survival

85 We describe murine monoclonal antibodies (mAbs) raised by immunizati

86 apeutic doses of 131I-labeled NP-4 and MN-14 murine monoclonal antibodies (MAbs) reactive with carcin

87 Murine monoclonal antibodies (MAbs) specific for toxic s

88 generated and biochemically characterized 33 murine monoclonal antibodies (mAbs) to FimH.

89 We generated and characterized murine monoclonal antibodies (mAbs) to SEB in mice.

90 Here, we generated a panel of eight murine monoclonal antibodies (MAbs) utilizing a prime-bo

91 A set of murine monoclonal antibodies (MAbs) was generated agains

92 ) to determine the reactivity patterns of 21 murine monoclonal antibodies (MAbs) with structurally de

93 We have isolated six new anti-CCR5 murine monoclonal antibodies (MAbs), designated PA8, PA9

94 e generated and subsequently characterized 7 murine monoclonal antibodies (MAbs), which fell into 4 d

95 ressed this question using quinine-dependent murine monoclonal antibodies (mAbs), which, in vitro and

96 serological studies and the analysis of many murine monoclonal antibodies (MAbs).

97 ish, Ictalurus punctatus, using immobilizing murine monoclonal antibodies (MAbs).

98 The Fab fragment of the murine monoclonal antibody, MAK33, directed against huma

99 in a phase I dose-escalation trial with the murine monoclonal antibody Mikbeta1.

100 Lym-2 is a murine monoclonal antibody (MoAb) directed towards a hum

101 s evaluated with a group of affinity-diverse murine monoclonal antibodies (MoAbs) specific for human

102 The anti-CD1a murine monoclonal antibody NA1/34 was investigated for i

103 Here, we demonstrate that the murine monoclonal antibody OKT9, which targets the apica

104 sted the hypothesis that the CA-125-specific murine monoclonal antibody, oregovomab, administered as

105 A humanized murine monoclonal antibody (palivizumab) is approved to

106 [Chemical reaction: See text] 29G12 is a murine monoclonal antibody programmed to catalyze the re

107 As a model system, murine monoclonal antibodies raised against Ad type 5 (A

108 6A6 is a murine monoclonal antibody raised against the humanized

109 ts with adenocarcinomas reactive to NR-LU-10 murine monoclonal antibody received the 3 components.

110 ABX-CBL, an immunoglobulin M murine monoclonal antibody, recognizes CD147 and initiat

111 Serological analysis and isolation of murine monoclonal antibodies revealed that immunization

112 ue immunoassays with human IgE antibodies or murine monoclonal antibodies showed that these allergens

113 Here we report the development of novel murine monoclonal antibodies specific for different G4 D

114 A panel of murine monoclonal antibodies specific for human cell-sur

115 We also identified novel murine monoclonal antibodies specific to citrullinated f

116 5D3 is a new high-affinity murine monoclonal antibody specific for prostate-specifi

117 Edrecolomab (ED) is a murine monoclonal antibody targeting the EpCam antigen.

118 N901 is a murine monoclonal antibody that binds to the CD56 (neura

119 avy- and light-chain variable regions from a murine monoclonal antibody that recognize Pseudomonas ae

120 Palivizumab, a humanized murine monoclonal antibody that recognizes antigenic sit

121 ilized Fv fragment (dsFv) was derived from a murine monoclonal antibody that recognizes the alpha sub

122 ensitive), each conjugated with mAb H18/7, a murine monoclonal antibody that recognizes the extracell

123 13F6-1-2 is a murine monoclonal antibody that recognizes the heavily g

124 We used previously characterized murine monoclonal antibodies to develop a panel useful i

125 adult bone marrow mononuclear cells using a murine monoclonal antibody to human platelet glycoprotei

126 We assessed the safety and efficacy of murine monoclonal antibody to human tumour necrosis fact

127 (Id)-bearing antibodies sharing an Id with a murine monoclonal antibody to myelin basic protein pepti

128 Both a murine monoclonal antibody to phosphatidylinositol phosp

129 We now determined the ability of a murine monoclonal antibody to the light chain of high mo

130 fragments of CB2, an immunoglobulin G1kappa murine monoclonal antibody, to an epitope in the carboxy

131 However, the murine monoclonal antibody triggered a potent humoral re

132 sis, we treated human endothelial cells with murine monoclonal antibody W6/32 to HLA class I and then

133 A panel of murine monoclonal antibodies was generated against the e

134 Since the first murine monoclonal antibody was approved for human therap

135 ssue, the binding site of KKO, an HIT/T-like murine monoclonal antibody, was defined.

136 Recently, quinine-dependent murine monoclonal antibodies were developed that recogni

137 22 different serovar-specific or bispecific murine monoclonal antibodies were localized with synthet

138 Murine monoclonal antibodies were produced against Burkh

139 Synthetic peptides and murine monoclonal antibodies were used to map cross-reac

140 thymectomized and treated with Ox8 and Ox38 murine monoclonal antibodies, which deplete CD8+ and CD4

141 d hybridoma technology for the generation of murine monoclonal antibodies with predetermined antigen-